baicalin has been researched along with Cognition Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Gao, P; Li, J; Li, X; Liang, H; Tu, Y; Zhang, S; Zhao, M | 1 |
Cao, YG; Li, XL; Liu, ZQ; Ma, P; Ma, Y; Mao, XY; Qiao, YD; Zhou, HH | 1 |
2 other study(ies) available for baicalin and Cognition Disorders
Article | Year |
---|---|
Baicalin attenuates alzheimer-like pathological changes and memory deficits induced by amyloid β1-42 protein.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cognition Disorders; Cytokines; Flavonoids; Immunohistochemistry; Macrophage Activation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Neuroglia; Peptide Fragments | 2015 |
Baicalin alleviates diabetes‑associated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brain‑derived neurotrophic factor and apoptosis.
Topics: Acetylcholinesterase; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Brain-Derived Neurotrophic Factor; Caspase 3; Choline O-Acetyltransferase; Cognition Disorders; Diabetes Mellitus, Experimental; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hippocampus; JNK Mitogen-Activated Protein Kinases; Male; Maze Learning; Memory; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Rats; Rats, Wistar; Streptozocin | 2015 |